BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia J, Liu SZ, Louie AY. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos Trans A Math Phys Eng Sci 2017;375:20170180. [PMID: 29038383 DOI: 10.1098/rsta.2017.0180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Webster AM, Peacock AFA. De novo designed coiled coils as scaffolds for lanthanides, including novel imaging agents with a twist. Chem Commun 2021;57:6851-62. [DOI: 10.1039/d1cc02013g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Caspani S, Magalhães R, Araújo JP, Sousa CT. Magnetic Nanomaterials as Contrast Agents for MRI. Materials (Basel) 2020;13:E2586. [PMID: 32517085 DOI: 10.3390/ma13112586] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
3 Kartamihardja AAP, Ariyani W, Hanaoka H, Taketomi-Takahashi A, Koibuchi N, Tsushima Y. The Role of Ferrous Ion in the Effect of the Gadolinium-Based Contrast Agents (GBCA) on the Purkinje Cells Arborization: An In Vitro Study. Diagnostics (Basel) 2021;11:2310. [PMID: 34943547 DOI: 10.3390/diagnostics11122310] [Reference Citation Analysis]
4 Maziero D, Straza MW, Ford JC, Bovi JA, Diwanji T, Stoyanova R, Paulson ES, Mellon EA. MR-Guided Radiotherapy for Brain and Spine Tumors. Front Oncol 2021;11:626100. [PMID: 33763361 DOI: 10.3389/fonc.2021.626100] [Reference Citation Analysis]
5 Sharma D, Subramaniam G, Sharma N, Sharma P, Sharma P. Insight into Noninvasive Radiological Modalities to Detect Heart Transplant Rejection. Indian J Radiol Imaging. [DOI: 10.1055/s-0041-1741098] [Reference Citation Analysis]
6 Ackermans N, Taylor C, Tam R, Carruthers R, Kolind S, Kang H, Freedman MS, Li DK, Traboulsee AL. Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Mult Scler J Exp Transl Clin 2019;5:2055217318823796. [PMID: 30800415 DOI: 10.1177/2055217318823796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Xiang LJ, Zhu XJ, Zhang HH, Yang L, Deng KX, Liu Y, Ye MS, Hu L, Yang XY, Zhou HP. A water-soluble, upconverting Sr2Yb0.3Gd0.7F7:Er3+/Tm3+@PSIoAm bio-probe for in vivo trimodality imaging. Nanoscale 2018;10:14414-20. [PMID: 29897095 DOI: 10.1039/c8nr03220c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Parker D, Long NJ, Faulkner S. Challenges for chemistry in molecular imaging. Philos Trans A Math Phys Eng Sci 2017;375:20170024. [PMID: 29038379 DOI: 10.1098/rsta.2017.0024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen K, Li P, Zhu C, Xia Z, Xia Q, Zhong L, Xiao B, Cheng T, Wu C, Shen C, Zhang X, Zhu J. Mn(II) Complex of Lipophilic Group-Modified Ethylenediaminetetraacetic Acid (EDTA) as a New Hepatobiliary MRI Contrast Agent. J Med Chem 2021;64:9182-92. [PMID: 34152137 DOI: 10.1021/acs.jmedchem.1c00393] [Reference Citation Analysis]
10 Tran HP, Jiang Y, Nguyen PH, Kim JJ, Yang SG. Retinoic acid-conjugated chitosan/manganese porphyrin ionic-complex nanoparticles for improved T1 contrast MR imaging of hepatic fibrosis. J Biomed Mater Res B Appl Biomater 2021. [PMID: 34309195 DOI: 10.1002/jbm.b.34914] [Reference Citation Analysis]
11 Marasini R, Rayamajhi S, Moreno-sanchez A, Aryal S. Iron( iii ) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T1 -weighted MRI contrast agent. RSC Adv 2021;11:32216-26. [DOI: 10.1039/d1ra05544e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Reeβing F, Szymanski W. Following nanomedicine activation with magnetic resonance imaging: why, how, and what's next? Curr Opin Biotechnol 2019;58:9-18. [PMID: 30390536 DOI: 10.1016/j.copbio.2018.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Stinnett G, Taheri N, Villanova J, Bohloul A, Guo X, Esposito EP, Xiao Z, Stueber D, Avendano C, Decuzzi P, Pautler RG, Colvin VL. 2D Gadolinium Oxide Nanoplates as T1 Magnetic Resonance Imaging Contrast Agents. Adv Healthc Mater 2021;10:e2001780. [PMID: 33882196 DOI: 10.1002/adhm.202001780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Reeßing F, Stuart MCA, Samplonius DF, Dierckx RAJO, Feringa BL, Helfrich W, Szymanski W. A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. Chem Commun 2019;55:10784-7. [DOI: 10.1039/c9cc05516a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
15 Werner P, Taupitz M, Schröder L, Schuenke P. An NMR relaxometry approach for quantitative investigation of the transchelation of gadolinium ions from GBCAs to a competing macromolecular chelator. Sci Rep 2021;11:21731. [PMID: 34741037 DOI: 10.1038/s41598-021-00974-4] [Reference Citation Analysis]
16 Patil R, Galstyan A, Grodzinski ZB, Shatalova ES, Wagner S, Israel LL, Ding H, Black KL, Ljubimova JY, Holler E. Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma. Int J Nanomedicine 2020;15:3057-70. [PMID: 32431501 DOI: 10.2147/IJN.S238265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Shi S, Vissapragada R, Abi Jaoude J, Huang C, Mittal A, Liu E, Zhong J, Kumar V. Evolving role of biomaterials in diagnostic and therapeutic radiation oncology. Bioact Mater 2020;5:233-40. [PMID: 32123777 DOI: 10.1016/j.bioactmat.2020.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
18 Haedicke IE, Loai S, Cheng HM. An Efficient T 1 Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI. Contrast Media Mol Imaging 2019;2019:3475786. [PMID: 31316306 DOI: 10.1155/2019/3475786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Gibby W, Parish W, Merrill RM, Fernandez D, Anderson CR, Merchel E, Parr R. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates? Magn Reson Imaging 2019;58:76-81. [PMID: 30639754 DOI: 10.1016/j.mri.2019.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ordak M, Sloniewicz N, Nasierowski T, Muszynska E, Bujalska-Zadrozny M. Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reports. Clin Toxicol (Phila) 2021;:1-8. [PMID: 34521308 DOI: 10.1080/15563650.2021.1973488] [Reference Citation Analysis]
21 Chen CW, Tseng YH, Lin CC, Kao CC, Wong MY, Ting H, Huang YK. Aortic dissection assessment by 4D phase-contrast MRI with hemodynamic parameters: the impact of stent type. Quant Imaging Med Surg 2021;11:490-501. [PMID: 33532250 DOI: 10.21037/qims-20-670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]